NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Major Shareholder Buys $21,875.07 in Stock

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) major shareholder Poplar Point Capital Partners acquired 31,703 shares of the stock in a transaction on Monday, January 27th. The stock was bought at an average price of $0.69 per share, with a total value of $21,875.07. Following the completion of the acquisition, the insider now directly owns 550,000 shares of the company’s stock, valued at $379,500. This trade represents a 6.12 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Poplar Point Capital Partners also recently made the following trade(s):

• On Friday, January 31st, Poplar Point Capital Partners bought 70,685 shares of NovaBay Pharmaceuticals stock. The stock was purchased at an average price of $0.65 per share, with a total value of $45,945.25.
• On Thursday, February 20th, Poplar Point Capital Partners purchased 1,836 shares of NovaBay Pharmaceuticals stock. The stock was purchased at an average cost of $0.63 per share, for a total transaction of $1,156.68.
• On Tuesday, February 18th, Poplar Point Capital Partners acquired 3,222 shares of NovaBay Pharmaceuticals stock. The shares were purchased at an average cost of $0.66 per share, with a total value of $2,126.52.
• On Monday, February 3rd, Poplar Point Capital Partners purchased 2,597 shares of NovaBay Pharmaceuticals stock. The stock was acquired at an average price of $0.64 per share, with a total value of $1,662.08.
• On Friday, March 7th, Poplar Point Capital Partners acquired 102 shares of NovaBay Pharmaceuticals stock. The shares were acquired at an average cost of $0.55 per share, for a total transaction of $56.10.
• On Tuesday, March 4th, Poplar Point Capital Partners bought 4,000 shares of NovaBay Pharmaceuticals stock. The shares were acquired at an average cost of $0.58 per share, with a total value of $2,320.00.
• On Thursday, February 27th, Poplar Point Capital Partners purchased 385 shares of NovaBay Pharmaceuticals stock. The stock was bought at an average price of $0.61 per share, for a total transaction of $234.85.
• On Tuesday, February 25th, Poplar Point Capital Partners acquired 25,033 shares of NovaBay Pharmaceuticals stock. The shares were bought at an average price of $0.62 per share, with a total value of $15,520.46.
• On Friday, March 14th, Poplar Point Capital Partners bought 25,511 shares of NovaBay Pharmaceuticals stock. The stock was bought at an average cost of $0.63 per share, for a total transaction of $16,071.93.
• On Wednesday, March 12th, Poplar Point Capital Partners purchased 11,837 shares of NovaBay Pharmaceuticals stock. The stock was bought at an average cost of $0.62 per share, with a total value of $7,338.94.

NovaBay Pharmaceuticals Trading Up 2.0 %

Shares of NBY opened at $0.60 on Friday. The company has a market cap of $3.49 million, a price-to-earnings ratio of -0.01 and a beta of 0.90. The business’s fifty day simple moving average is $0.60 and its two-hundred day simple moving average is $0.63. NovaBay Pharmaceuticals, Inc. has a 12 month low of $0.36 and a 12 month high of $9.08.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on shares of NovaBay Pharmaceuticals in a report on Friday. They issued a “hold” rating for the company.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc, a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands.